Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARMH2, or armadillo-like helical domain-containing protein 2, is a protein encoded by the ARMH2 gene (HGNC:49394), also known as C6orf229. It belongs to the armadillo repeat-containing protein family, which typically function as scaffolds for protein-protein interaction and may play roles in cellular processes such as signal transduction and mitochondrial regulation. While family members, such as β-catenin, have important roles in cell signaling and disease, ARMH2 itself has not been characterized in detail, and its precise biological function, disease associations, and therapeutic relevance remain unestablished. It is currently classified as a "protein-coding gene" without further functional annotation, and is not considered a therapeutic target, receptor, enzyme, or biomarker in any known context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Armadillo-like helical domain-containing protein 2 (ARMH2).